G E Umpierrez
- Immunogenetic analysis suggests different pathogenesis for obese and lean African-Americans with diabetic ketoacidosisG E Umpierrez
Department of Medicine, Emory University, Atlanta, Georgia 30312, USA
Diabetes Care 22:1517-23. 1999..The aim of this study was to determine whether obese African-American patients with DKA could be determined to have type 1 or type 2 diabetes based on insulin secretion or the presence of immunological and genetic markers...
- The effects of LY2189265, a long-acting glucagon-like peptide-1 analogue, in a randomized, placebo-controlled, double-blind study of overweight/obese patients with type 2 diabetes: the EGO studyG E Umpierrez
Emory School of Medicine, Emory University, Atlanta, GA 30303, USA
Diabetes Obes Metab 13:418-25. 2011..To evaluate the efficacy and tolerability of once-weekly LY2189265 (LY), a novel glucagon-like peptide-1 (GLP-1) IgG4-Fc fusion protein, in patients with type 2 diabetes failing oral antihyperglycaemic medications (OAMs)...
- Management of type 2 diabetes. Evolving strategies for treatmentG E Umpierrez
Department of Medicine, Division of Endocrinology, Diabetes, and Metabolism, University of Tennessee Health Science Center, Memphis, Tennessee, USA
Obstet Gynecol Clin North Am 28:401-19, viii. 2001..This article examines the current classification, diagnostic criteria for diabetes, and screening recommendations and provides a therapeutic strategy for improving glycemic control in patients with type 2 diabetes...
- Effects of nebivolol in obese African Americans with hypertension (NOAAH): markers of inflammation and obesity in response to exercise-induced stressN Merchant
Division of Cardiology, Department of Medicine, Emory University School of Medicine, Atlanta, GA, USA
J Hum Hypertens 25:196-202. 2011..Moreover, this effect is potentiated in response to exercise-induced stress. These results suggest that nebivolol differentially regulates markers of inflammation and obesity, thereby providing vascular protection...